GOP Push for Mifepristone Ban Gains Momentum

Senator Josh Hawley (R-Mo.) has introduced the Safeguarding Women from Chemical Abortion Act, aiming to revoke the Food and Drug Administration’s (FDA) approval of mifepristone, a drug used in medication abortions. The legislation has garnered support from Senators John Cornyn (R-Texas), Ted Budd (R-N.C.), and Marsha Blackburn (R-Tenn.), marking a significant push within the Republican Party to restrict access to this medication. The bill would classify the distribution and labeling of mifepristone as violations of the Food, Drug, and Cosmetic Act and allow women harmed by the drug to sue its manufacturers.

The HillHawley bill banning abortion drug gains steam in US SenateNOTUS

Hawley argues that the widespread availability of mifepristone undermines the Supreme Court's 2022 decision to overturn Roe v. Wade, which aimed to empower states to regulate abortion. He contends that the ability to order mifepristone online circumvents state laws designed to restrict abortions. In a letter to his colleagues, he emphasized the health risks associated with the drug, citing a study claiming that 11% of women experienced serious health effects after taking mifepristone, a figure disputed by the FDA, which estimates the rate at 0.5%.

The HillHawley bill banning abortion drug gains steam in US SenateNOTUS

While the bill has received backing from many Republican senators, there is notable dissent within the party. Some members, such as Rep. Max Miller (R-Ohio), argue that abortion should be regulated at the state level rather than through federal legislation. Miller expressed concern that the anti-abortion rhetoric may have unintended consequences, citing Ohio's recent constitutional amendment that expanded abortion rights. Other Republicans, including Rep. Mike Lawler (R-N.Y.), have also voiced opposition, suggesting that the party should focus on economic issues rather than abortion.

NOTUSThe Hill

The push for the mifepristone ban reflects a broader strategy among some Republicans to re-engage with the abortion issue following the Supreme Court's decision. Hawley views this legislation as a crucial step for the pro-life movement, stating, “This is the future of the life movement; it’s going to be about mifepristone.” However, the bill is unlikely to advance in the Senate without Democratic support, and many Republicans in competitive districts are hesitant to align with the legislation.

The HillNOTUSHawley bill banning abortion drug gains steam in US Senate

Hawley has called for Republican unity in supporting the bill, arguing that it addresses a significant health threat to women. He stated, “Congress can no longer ignore these dangers,” highlighting the need for accountability from drug manufacturers. Conversely, some Republicans have indicated that the party should prioritize other issues, such as government funding and economic reforms, over abortion.

NOTUS

There is a discrepancy regarding the reported health risks associated with mifepristone. While Hawley cites a study indicating a higher rate of serious adverse effects, the FDA and other studies suggest a much lower incidence. This divergence highlights the ongoing debate over the safety and regulation of abortion medications.

The Hill

• “Every pro-life group has endorsed this bill,” — Senator Josh Hawley

The Hill

• “I think what we should be focusing on right now is funding the government, get DHS back open, pass the farm bill, getting permitting reform done and working on things that actually make our economy better and make our country stronger,” — Rep. David Valadao

NOTUS

• “He said abortion is an issue that “should reside” at the state level.” — Rep. Max Miller

NOTUS

The future of Hawley’s legislation remains uncertain as the Republican Party navigates internal divisions and public sentiment on abortion ahead of the upcoming elections.

NOTUS